title: Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors.
authors: Department of Pathology and Bosch Institute, University of Sydney, Sydney, New South Wales 2006, Australia.
authors: Yu
authors: Y
authors: Yu
authors: Danuta S
authors: DS
authors: Kalinowski
authors: Zaklina
authors: Z
authors: Kovacevic
authors: Aritee R
authors: AR
authors: Siafakas
authors: Patric J
authors: PJ
authors: Jansson
authors: Christian
authors: C
authors: Stefani
authors: David B
authors: DB
authors: Lovejoy
authors: Philip C
authors: PC
authors: Sharpe
authors: Paul V
authors: PV
authors: Bernhardt
authors: Des R
authors: DR
authors: Richardson
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000737:chemistry / Q000378:metabolism; D007502:Iron Chelating Agents / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors*; D013882:Thiosemicarbazones / Q000737:chemistry* / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D007502:Iron Chelating Agents; D013882:Thiosemicarbazones; D007501:Iron; D012264:Ribonucleotide Reductases